UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma

Proceedings of the National Academy of Sciences - PNAS, 2012-01, Vol.109 (2), p.570-575

2012

Volltextzugriff (PDF)

Increased Risk of Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Pharmacotherapy, 2008-12, Vol.28 (12), p.1511-1522

2008

Volltextzugriff (PDF)

Locally Advanced Prostate Cancer Treated With Concomitant Radiation and 5-Fluorouracil: Southwest Oncology Group Study 9024

The Journal of urology, 2006-08, Vol.176 (2), p.548-553

2006

Volltextzugriff (PDF)

Effect of single agent high-dose methotrexate-related acute kidney injury on length of hospitalization and relative dose intensity in adult patients with central nervous system lymphoma

Journal of oncology pharmacy practice, 2017-10, Vol.23 (7), p.496-501

2017

Volltextzugriff (PDF)

Cost savings from dose rounding of biologic anticancer agents in adults

Journal of oncology pharmacy practice, 2011-09, Vol.17 (3), p.246-251

2011

Volltextzugriff (PDF)

Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer

Molecular cancer therapeutics, 2010-08, Vol.9 (8), p.2423-2429

2010

Volltextzugriff (PDF)

Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate

Journal of oncology pharmacy practice, 2012-06, Vol.18 (2), p.239-244

2012

Volltextzugriff (PDF)

Clinical activity, safety and tolerability of ASN002, a dual SYK/JAK inhibitor, in patients non-Hodgkin lymphoma (NHL) and solid tumors

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.7545-7545

2017

Volltextzugriff (PDF)

A phase 1 study of ALX148, a CD47 blocker, alone and in combination with established anticancer antibodies in patients with advanced malignancy and non-Hodgkin lymphoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.3068-3068

2018

Volltextzugriff (PDF)

Results of a phase Ib study of ARQ 092 in combination with carboplatin (C) plus paclitaxel (P), or with P in patients (pts) with solid tumors

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2524-2524

2017

Volltextzugriff (PDF)

A phase I study of novel dual Bcl-2/Bcl-xL inhibitor APG-1252 in patients with advanced small cell lung cancer (SCLC) or other solid tumor

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2594-2594

2018

Volltextzugriff (PDF)

A first-in-class, first-in-human phase 1 pharmacokinetic (PK) and pharmacodynamic (PD) study of Hu5F9-G4, an anti-CD47 monoclonal antibody (mAb), in patients with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.3002-3002

2018

Volltextzugriff (PDF)

Hemophagocytic syndrome: A cause of pancytopenia in human ehrlichiosis

American journal of hematology, 1991-11, Vol.38 (3), p.230-234

1991

Volltextzugriff (PDF)

Here's my advice

ABA Bank Marketing, 2003-06, Vol.35 (5), p.38

O'Rourke, Timothy J

2003

Volltextzugriff (PDF)

Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil : Southwest oncology group study 9024. Commentary

The Journal of urology, 2006, Vol.176 (2), p.548-553

2006

Volltextzugriff (PDF)

Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea

American journal of hematology, 1996-02, Vol.51 (2), p.137-140

1996

Volltextzugriff (PDF)

Interobserver variability in prostate cancer specific survival

Urologic oncology, 1998, Vol.4 (1), p.13-16

1998

Volltextzugriff (PDF)

Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies

Investigational new drugs, 1998-01, Vol.16 (1), p.19-27

1998

Volltextzugriff (PDF)

Phase I clinical and pharmacokinetic trial of brequinar sodium (DUP 785; NSC 368390)

Cancer research (Chicago, Ill.), 1989-08, Vol.49 (16), p.4648-4653

1989

Volltextzugriff (PDF)

Testicular relapse in adult acute myelogenous leukemia

Cancer, 1992-09, Vol.70 (6), p.1541-1544

1992

Volltextzugriff (PDF)

Pyramid power

Credit Union Management, 1999-09, Vol.22 (9), p.20

O'Rourke, J Timothy

1999

Volltextzugriff (PDF)

Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)

Anti-cancer drugs, 1994-10, Vol.5 (5), p.520-526

1994

Volltextzugriff (PDF)

In search of incentives

Credit union management, 1998-08, Vol.21 (8), p.14

O'Rourke, J Timothy

1998

Volltextzugriff (PDF)

"Broadcasters Considering an LMA Need to Consider a Range of Issues"

Broadcasting & cable, 1992-03, Vol.122 (10), p.71

1992

Volltextzugriff (PDF)

Monday Memo: "Broadcasters Considering an LMA Need to Consider a Range of Issues."

Broadcasting, 1992-03, Vol.122 (10), p.71

1992

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(115)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(62)
Humans
(59)
Male
(35)
Female
(33)
Biological And Medical Sciences
(28)
Adult
(25)
Medical Sciences
(25)
Middle Aged
(24)
Aged
(21)
Oncology
(17)
Animals
(13)
Multidisciplinary Sciences
(11)
Science & Technology - Other Topics
(11)
Cardiac & Cardiovascular Systems
(10)
Cardiovascular System & Cardiology
(10)
Adolescent
(9)
Pharmacology. Drug Treatments
(9)
Chemotherapy
(8)
Mice
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma

Increased Risk of Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Locally Advanced Prostate Cancer Treated With Concomitant Radiation and 5-Fluorouracil: Southwest Oncology Group Study 9024

Effect of single agent high-dose methotrexate-related acute kidney injury on length of hospitalization and relative dose intensity in adult patients with central nervous system lymphoma

Cost savings from dose rounding of biologic anticancer agents in adults

Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer

Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate

Clinical activity, safety and tolerability of ASN002, a dual SYK/JAK inhibitor, in patients non-Hodgkin lymphoma (NHL) and solid tumors

A phase 1 study of ALX148, a CD47 blocker, alone and in combination with established anticancer antibodies in patients with advanced malignancy and non-Hodgkin lymphoma

Results of a phase Ib study of ARQ 092 in combination with carboplatin (C) plus paclitaxel (P), or with P in patients (pts) with solid tumors

A phase I study of novel dual Bcl-2/Bcl-xL inhibitor APG-1252 in patients with advanced small cell lung cancer (SCLC) or other solid tumor

A first-in-class, first-in-human phase 1 pharmacokinetic (PK) and pharmacodynamic (PD) study of Hu5F9-G4, an anti-CD47 monoclonal antibody (mAb), in patients with advanced solid tumors

Hemophagocytic syndrome: A cause of pancytopenia in human ehrlichiosis

Here's my advice

Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil : Southwest oncology group study 9024. Commentary

Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea

Interobserver variability in prostate cancer specific survival

Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies

Phase I clinical and pharmacokinetic trial of brequinar sodium (DUP 785; NSC 368390)

Testicular relapse in adult acute myelogenous leukemia

Pyramid power

Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)

In search of incentives

"Broadcasters Considering an LMA Need to Consider a Range of Issues"

Monday Memo: "Broadcasters Considering an LMA Need to Consider a Range of Issues."

Suchergebnisse filtern